Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats

Acta Odontologica Scandinavica

Volumn 65, Issue 6, 2007, Pages 348-351

  Verzeletti, Giliano Nicolini ^a   Gaio, Eduardo José ^b   Rösing, Cassiano Kuchenbecker ^a,b  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cytokines; Interleukin 1; Periodontal disease; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1; METHOTREXATE; TUMOR NECROSIS FACTOR;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE COMPARISON; MALE; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; PATHOGENESIS; PERIODONTITIS; RANDOMIZATION; RAT; STATISTICAL SIGNIFICANCE; STUDENT T TEST; WISTAR RAT;

ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFECTIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERLEUKIN-1; MALE; METHOTREXATE; PERIODONTITIS; RANDOM ALLOCATION; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37049014261     PISSN: 00016357     EISSN: 15023850     Source Type: Journal    
DOI: 10.1080/00016350701742364     Document Type: Article

References (26)

1. Kinane DF. Causation and pathogenesis of periodontal disease. Periodontol 2000 2001;25:8-20.
2. Madianos PN, Bobetsis YA, Kinane DF. Generation of inflammatory stimuli: How bacteria set up inflammatory responses in the gingiva. J Clin Periodontol 2005;32 Suppl 6:57-71.
3. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991;26:230-42.
4. Graves DT, Delima AJ, Assuma R, Amar S, Oates T, Cochran D. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 1998;69:1419-25.
5. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401.
6. Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransky S. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 1991;62:504-9.
7. Tervahartiala T, Koski H, Xu JW, Häyrinen-Immonen R, Hietanen J, Sorsa T, et al. Tumor necrosis factor-α and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 2001;80:1535-9.
8. Figueredo CM, Ribeiro MS, Fischer RG, Gustafsson A. Increased interleukin-1beta concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 1999;70:1457-63.
9. Koide M, Suda S, Saitoh S, Ofuji Y, Suzuki T, Yoshie H, et al. In vivo administration of IL-1 beta accelerates silk ligature-induced alveolar bone resorption in rats. J Oral Pathol Med 1995;24:420-34.
10. Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U. Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 2003;38:198-203.
11. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998;160:403-9.
12. Oates TW, Graves DT, Cochran DL. Clinical, radiographic and biochemical assessment of IL-1/TNF-alpha antagonist inhibition of bone loss in experimental periodontitis. J Clin Periodontol 2002;29:137-43.
13. de Lima V, Bezerra MM, de Menezes Alencar VB, Vidal FD, da Rocha FA, de Castro Brito GA, et al. Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. Eur J Oral Sci 2000;108:123-9.
14. Lima V, Vidal FD, Rocha FA, Brito GA, Ribeiro RA. Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats. J Periodontol 2004;75:162-8.
15. Cronstein BN. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 1996;39:1951-60.
16. Cutolo M, Bisso A, Sulli A, Felli L, Briata M, Pizzorni C, et al. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis. J Rheumatol 2000;27:2551-7.
17. Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub RH. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis 2001;60:729-35.
18. Yoshinari N, Kameyama Y, Aoyama Y, Nishiyama H, Noguchi T. Effect of long-term methotrexate-induced neutropenia on experimental periodontal lesion in rats. J Periodontal Res 1994;29:393-400.
19. Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. QJM 2001;94:309-19.
20. Björnsson MJ, Velschow S, Stoltze K, Havemose-Poulsen A, Schou S, Holmstrup P. The influence of diet consistence, drinking water and bedding on periodontal disease in Sprague-Dawley rats. J Periodontal Res 2003;38:543-50.
21. Cegiela U, Sliwinski L, Kaczmarczyk-Sedlak I, Folwarczna J. In vivo effects of high-dose methotrexate on bone remodeling in rats. Pharmacol Rep 2005;57:504-14.
22. Sakuma S, Nishigaki F, Magari K, Ogawa T, Miyata S, Ohkubo Y, et al. FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis. Inflamm Res 2001;50:509-14.
23. Susin C, Rösing CK. Effect of variable moderate chronic stress on ligature-induced periodontal disease in Wistar rats. Acta Odontol Scand 2003;61:273-7.
24. Cavagni J, Soletti AC, Gaio EJ, Rösing CK. The effect of dexamethasone in the pathogenesis of ligature-induced periodontal disease in Wistar rats. Braz Oral Res 2005;19:290-4.
25. Grauballe MC, Bentzen BH, Björnsson M, Moe D, Jonassen TE, Bendtzen K, et al. The effect of spironolactone on experimental periodontitis in rats. J Periodontal Res 2005;40:212-7.
26. Sacket D. Evidence-based medicine: How to practice and teach EBM. New York: Churchill Livingtone; 2000.